Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Complement factor H

EU orphan designation number: EU/3/06/425
Active ingredient: Complement factor H
Indication: Treatment of atypical Haemolytic Uraemic Syndrome (aHUS) associated with an inherited abnormality of the complement system
Sponsor: Laboratoire français du Fractionnement et des Biotechnologies (LFB) S.A.
3 avenue des Tropiques, BP 80097, F-91943 Courtaboeuf CEDEX, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/01/2007 Orphan designation EMEA/OD/080/06 (2007)317 of 26/01/2007
13/06/2012 Removal of orphan designation from Community Register